Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

The report provides a detailed analysis of the current acute respiratory distress syndrome (ARDS) marketed drugs and late-stage pipeline drugs. Inside the ARDS Market | How Tech, Awareness, Rising ...

Both dyspnea and respiratory drive went down with vs. without nasal high-flow therapy in orally intubated patients, according ...